Aridis Pharmaceuticals (ARDS)
OTHER OTC:ARDS
US Market
Holding ARDS?
Track your performance easily

Aridis Pharmaceuticals (ARDS) Financial Statements

209 Followers

Aridis Pharmaceuticals Financial Overview

Aridis Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-0.156; its P/E ratio is -0.41; Aridis Pharmaceuticals is scheduled to report earnings on November 20, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue-$ 19.65M$ 1.08M$ 1.21M$ 399.00K
Gross Profit$ 417.00K$ 19.65M$ 1.08M$ 1.21M$ 399.00K
EBIT$ -869.00K$ 13.70M$ 6.67M$ -7.39M$ -7.39M
EBITDA$ -810.00K$ 13.76M$ 6.75M$ -7.88M$ -7.26M
Net Income Common Stockholders$ -83.00K$ 12.14M$ 6.06M$ -6.39M$ -8.24M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 35.00K$ 19.00K$ 1.32M$ 5.06M$ 2.63M
Total Assets$ 6.53M$ 6.48M$ 9.43M$ 14.70M$ 12.12M
Total Debt$ 4.84M$ 6.29M$ 1.91M$ 6.13M$ 14.08M
Net Debt$ 4.80M$ 6.28M$ 586.00K$ 1.07M$ 11.45M
Total Liabilities$ 18.34M$ 21.40M$ 37.32M$ 38.93M$ 47.94M
Stockholders Equity$ -11.80M$ -14.94M$ -27.88M$ -24.23M$ -35.82M
Cash Flow-
Free Cash Flow$ -983.00K$ -4.33M$ -4.00M$ -8.61M$ -4.26M
Operating Cash Flow$ -983.00K$ -4.34M$ -4.00M$ -8.56M$ -4.26M
Investing Cash Flow-$ 14.00K-$ -49.00K-
Financing Cash Flow$ 999.00K$ 3.03M$ 263.00K$ 11.03M$ -554.00K
Currency in USD

Aridis Pharmaceuticals Earnings and Revenue History

Aridis Pharmaceuticals Debt to Assets

Aridis Pharmaceuticals Cash Flow

Aridis Pharmaceuticals Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis